The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years
- PMID: 2295475
- DOI: 10.1002/hep.1840110114
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years
Abstract
Forty-two patients with nonalcoholic steatohepatitis were followed for a median of 4.5 yr (range = 1.5 to 21.5 yr). Except for two patients with lipodystrophy, all were obese; 35 of 42 were women, 26 of 32 were hyperlipidemic and 15 were hyperglycemic. Upper abdominal pain was the most common reason for presentation. Initial liver biopsy specimens showed the presence of macrovesicular fatty infiltration, lobular (acinar) inflammation, apoptosis, Mallory bodies (in four cases) and fibrosis (in 18 cases). Cirrhosis was present at initial diagnosis in one subject and in another two subjects liver biopsy showed marked fibrosis with disturbed architecture. Serial liver biopsy specimens revealed minimal or no apparent progression of the disorder in most of the patients, in keeping with their benign clinical course. However, one patient showed progression from fibrosis to cirrhosis during the 5-yr observation period, and in the patients with extensive fibrosis the liver disease evolved from one of active inflammation to one of inactive cirrhosis without fat or inflammation. The patient with cirrhosis later died of hepatocellular carcinoma. The severity or type of hepatic change did not correlate with the degree of obesity, hyperlipidemia or hyperglycemia. However, in individual patients, poorly controlled diabetes and rapid weight loss preceded the onset of steatohepatitis. We conclude that nonalcoholic steatohepatitis is a cause of hepatic inflammation histologically resembling that of alcohol-induced liver disease but usually slowly progressive and of low-grade severity. However, the disorder may ultimately result in cirrhosis. Nonalcoholic steatohepatitis should be distinguished from alcoholic steatohepatitis and recognized as a further cause of "cryptogenic cirrhosis."
Comment in
-
The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.J Hepatol. 2004 Apr;40(4):578-84. doi: 10.1016/j.jhep.2004.02.013. J Hepatol. 2004. PMID: 15030972 No abstract available.
Similar articles
-
Two cases from the spectrum of nonalcoholic steatohepatitis.J Clin Gastroenterol. 1995 Mar;20(2):127-30. doi: 10.1097/00004836-199503000-00011. J Clin Gastroenterol. 1995. PMID: 7769192
-
Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.Dig Dis Sci. 1996 Jan;41(1):172-9. doi: 10.1007/BF02208601. Dig Dis Sci. 1996. PMID: 8565753
-
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.Hepatology. 1999 Dec;30(6):1356-62. doi: 10.1002/hep.510300604. Hepatology. 1999. PMID: 10573511
-
Obesity and hepatocellular carcinoma.Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. doi: 10.1053/j.gastro.2004.09.021. Gastroenterology. 2004. PMID: 15508109 Review.
-
Liver pathology in obesity.Semin Liver Dis. 2004 Nov;24(4):363-70. doi: 10.1055/s-2004-860865. Semin Liver Dis. 2004. PMID: 15605304 Review.
Cited by
-
Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.JHEP Rep. 2021 Feb 26;3(3):100261. doi: 10.1016/j.jhepr.2021.100261. eCollection 2021 Jun. JHEP Rep. 2021. PMID: 34036255 Free PMC article. Review.
-
In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained.Virchows Arch. 2013 May;462(5):533-40. doi: 10.1007/s00428-013-1402-8. Epub 2013 Mar 28. Virchows Arch. 2013. PMID: 23536281 Free PMC article.
-
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis.Int J Mol Sci. 2020 Oct 13;21(20):7543. doi: 10.3390/ijms21207543. Int J Mol Sci. 2020. PMID: 33066113 Free PMC article. Review.
-
Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation.Cell Cycle. 2015;14(14):2274-84. doi: 10.1080/15384101.2015.1046654. Epub 2015 May 6. Cell Cycle. 2015. PMID: 25946468 Free PMC article.
-
Correlation of the Fatty Liver Index with the Pathophysiological Abnormalities Associated with Cardiovascular Risk Markers in Japanese Men without any History of Cardiovascular Disease: Comparison with the Fibrosis-4 Score.J Atheroscler Thromb. 2021 May 1;28(5):524-534. doi: 10.5551/jat.56945. Epub 2020 Jul 23. J Atheroscler Thromb. 2021. PMID: 32713932 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical